Cirm;recurrent tumors;CAR T-cell therapy

Children’s Hospital Los Angeles Awarded $6 Million from CIRM to Advance CAR T-Cell Therapies in Children with Recurring Solid Tumors

[ad_1] Newswise — LOS ANGELES (February 29, 2024)—Children’s Hospital Los Angeles has received a multi-year $6 million award from the…